Providence Capital Advisors, LLC Novartis Ag Transaction History

Providence Capital Advisors, LLC

  • $445 Million
  • Q2 2024

A detailed history of Providence Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 35,533 shares of NVS stock, worth $3.93 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
35,533
Previous 35,117 1.18%
Holding current value
$3.93 Million
Previous $3.4 Million 11.37%
% of portfolio
0.85%
Previous 0.76%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $38,509 - $44,665
416 Added 1.18%
35,533 $3.78 Million
Q1 2024

May 13, 2024
SELL
$95.27 - $108.47 $27,628 - $31,456
-290 Reduced 0.82%
35,117 $3.4 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $18,282 - $20,290
193 Added 0.55%
35,407 $3.61 Million
Q2 2023

Aug 10, 2023
BUY
$92.52 - $104.91 $47,925 - $54,343
518 Added 1.49%
35,214 $3.55 Million
Q1 2023

May 17, 2023
BUY
$80.03 - $92.81 $255 Million - $296 Million
3,191,705 Added 782280.62%
3,192,113 $294 Million
Q1 2023

May 17, 2023
SELL
$80.03 - $92.81 $253 Million - $293 Million
-3,157,417 Reduced 98.91%
34,696 $3.19 Million
Q1 2023

May 10, 2023
SELL
$80.03 - $92.81 $2.7 Million - $3.13 Million
-33,700 Reduced 98.8%
408 $37,000
Q4 2022

Feb 07, 2023
SELL
$75.55 - $92.52 $151 - $185
-2 Reduced 0.01%
34,108 $3.09 Million
Q3 2022

Nov 09, 2022
BUY
$74.61 - $87.26 $52,077 - $60,907
698 Added 2.09%
34,110 $2.59 Million
Q2 2022

Aug 09, 2022
BUY
$80.52 - $93.75 $853,109 - $993,281
10,595 Added 46.43%
33,412 $2.82 Million
Q1 2022

May 12, 2022
BUY
$80.11 - $90.62 $147,001 - $166,287
1,835 Added 8.75%
22,817 $2 Million
Q4 2021

Feb 11, 2022
BUY
$79.7 - $88.13 $66,390 - $73,412
833 Added 4.13%
20,982 $1.84 Million
Q3 2021

Nov 09, 2021
BUY
$81.78 - $95.14 $151,865 - $176,674
1,857 Added 10.15%
20,149 $1.65 Million
Q2 2021

Aug 09, 2021
BUY
$85.24 - $94.15 $93,337 - $103,094
1,095 Added 6.37%
18,292 $1.67 Million
Q1 2021

May 13, 2021
BUY
$83.5 - $98.47 $31,062 - $36,630
372 Added 2.21%
17,197 $1.47 Million
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $133,890 - $161,947
1,715 Added 11.35%
16,825 $1.59 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $40,084 - $44,408
488 Added 3.34%
15,110 $1.31 Million
Q2 2020

Aug 04, 2020
SELL
$80.93 - $91.1 $9,873 - $11,114
-122 Reduced 0.83%
14,622 $1.28 Million
Q1 2020

May 12, 2020
BUY
$70.67 - $99.01 $1.04 Million - $1.46 Million
14,744 New
14,744 $1.22 Million
Q1 2018

May 10, 2018
SELL
$70.39 - $84.15 $3,167 - $3,786
-45 Closed
0 $0
Q4 2017

Feb 12, 2018
BUY
$72.33 - $77.64 $3,254 - $3,493
45
45 $4,000

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Providence Capital Advisors, LLC Portfolio

Follow Providence Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email